Sensus Healthcare Inc

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

SRTS$3.30+3.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income (Loss) (unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

For the Three Months Ended · For the Nine Months Ended
	September 30,		September 30,
(in thousands, except shares and per share data)	2024	2023	2024	2023
Revenues	$8,839	$3,898	$28,741	$11,838
Cost of sales	3,599	1,909	11,416	5,609
Gross profit	5,240	1,989	17,325	6,229
Operating expenses
Selling and marketing	1,309	1,290	3,575	4,983
General and administrative	1,573	1,511	4,731	4,204
Research and development	863	1,083	2,655	3,001
Total operating expenses	3,745	3,884	10,961	12,188
Income (loss) from operations	1,495	(1,895)	6,364	(5,959)
Other income:
Gain on sale of assets	-	42	-	42
Interest income, net	279	277	702	764
Other income, net	279	319	702	806
Income (loss) before income tax	1,774	(1,576)	7,066	(5,153)
Provision for (benefit from) income taxes	559	(125)	1,965	(1,428)
Net income (loss)	$1,215	$(1,451)	$5,101	$(3,725)
Net income (loss) per share – basic	$0.07	$(0.09)	$0.31	$(0.23)
diluted	$0.07	$(0.09)	$0.31	$(0.23)
Weighted average number of shares used in computing net income (loss) per share – basic	16,321,131	16,270,403	16,304,913	16,255,263
diluted	16,345,749	16,270,403	16,332,485	16,255,263

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.